SEC Comment Letter for AGENUS INC (AGEN) (CIK 0001098972) (AGEN) — Jan 25, 2017
AGENUS INC (AGEN) (CIK 0001098972)
Date: Jan. 25, 2017 · CIK: 0001098972 · Accession: 0000000000-17-002645
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-215640
Letter
Mail Stop 4546 January 25, 201 7 Garo H. Armen Chief Executive Officer and Chairman of the Board Agenus Inc. 3 Forbes Road Lexington, MA 02421
Re: Agenus Inc. Registration Statement on Form S-3 Filed January 20, 2017 File No. 333-215640
Dear Mr. Armen :
We have limited our review of your registration statement to those issues we have addressed in our comment.
Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in y our response.
After reviewing any amendment to your registration statement and the information you provide in response to th is comment, we may have additional comments.
General
1. We note that you have a pending request for confidential treatment . Please be advised that we will not be in a position to declare your registration statement effective until we resolve any issues concerning the confidential treatment request.
We remind you that the company and its management are responsible for the acc uracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement.
Garo H. Armen Agenus Inc. January 25 , 2017 Page 2
Please contact Jeffrey Gabor at (202) 551 -2544 or Suzanne Hayes at (202) 551 -3675 with any questions.
Sincerely,
/s/ Suzanne Hayes
Show Raw Text
Mail Stop 4546 January 25, 201 7 Garo H. Armen Chief Executive Officer and Chairman of the Board Agenus Inc. 3 Forbes Road Lexington, MA 02421 Re: Agenus Inc. Registration Statement on Form S-3 Filed January 20, 2017 File No. 333-215640 Dear Mr. Armen : We have limited our review of your registration statement to those issues we have addressed in our comment. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in y our response. After reviewing any amendment to your registration statement and the information you provide in response to th is comment, we may have additional comments. General 1. We note that you have a pending request for confidential treatment . Please be advised that we will not be in a position to declare your registration statement effective until we resolve any issues concerning the confidential treatment request. We remind you that the company and its management are responsible for the acc uracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement. Garo H. Armen Agenus Inc. January 25 , 2017 Page 2 Please contact Jeffrey Gabor at (202) 551 -2544 or Suzanne Hayes at (202) 551 -3675 with any questions. Sincerely, /s/ Suzanne Hayes Suzanne Hayes Assistant Director Office of Healthcare and Insurance cc: Zachary Blume , Esq. Ropes & Gray LLP